Syndax Pharmaceuticals, Inc. (SNDX) has a consensus analyst rating of Buy, based on 22 analysts covering the stock. Of those, 20 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for SNDX is $39.33, representing a +61.0% upside from the current price of $24.43. Price targets range from a low of $35.00 to a high of $45.00.
